Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors (Q41143898)
Jump to navigation
Jump to search
scientific article published on 19 June 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors |
scientific article published on 19 June 2017 |
Statements
1 reference
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors (English)
1 reference
Kyoichi Kaira
1 reference
Koichi Minato
1 reference
Hisao Imai
1 reference
Yosuke Miura
1 reference
Reiko Sakurai
1 reference
Yoshio Tomizawa
1 reference
Noriaki Sunaga
1 reference
Takeshi Hisada
1 reference
Tetsunari Oyama
1 reference
Masanobu Yamada
1 reference
19 June 2017
1 reference
1 reference
14
1 reference
2
1 reference
2369-2378
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference